Pharmacotherapy for lumbago
Nonspecific low back pain (NLBP) is one of the most common rheumatic disorders; it is responsible for the greatest number of patients seeking medical advice. Unfortunately, there is neither a generally acknowledged viewpoint on the nature of this pathology nor a unified conception of its treatment i...
Saved in:
| Main Author: | A.E. Karateev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2014-05-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/539 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pharmacotherapy of low back pain
by: Oppel BW Greeff
Published: (2018-03-01) -
Acute nonspecific (musculoskeletal) low back pain Guidelines of the Russian Society for the Study of Pain (RSSP)
by: V. A. Parfenov, et al.
Published: (2018-06-01) -
An integrated approach to the treatment of vertebrogenic pain
by: M. B. Klimycheva
Published: (2023-11-01) -
Etoricoxib can be used for chronic nonspecific back pain: a new indication of the well-known drug
by: A. E. Karateev
Published: (2020-04-01) -
Central muscle relaxants in rheumatology practice
by: E. Yu. Polishchuk, et al.
Published: (2021-12-01)